Legal & General Group Plc - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$3,000
-66.7%
6,8440.0%0.00%
Q1 2019$9,000
+12.5%
6,8440.0%0.00%
Q4 2018$8,000
-57.9%
6,8440.0%0.00%
Q3 2018$19,000
-20.8%
6,8440.0%0.00%
Q2 2018$24,000
-17.2%
6,844
-28.6%
0.00%
Q1 2018$29,000
-64.6%
9,586
-26.7%
0.00%
Q4 2017$82,000
-16.3%
13,077
-8.9%
0.00%
Q3 2017$98,000
+30.7%
14,360
+44.2%
0.00%
Q2 2017$75,000
-18.5%
9,9580.0%0.00%
Q1 2017$92,000
+80.4%
9,958
-19.0%
0.00%
Q4 2016$51,000
+142.9%
12,301
+125.0%
0.00%
Q3 2016$21,000
-27.6%
5,467
-19.1%
0.00%
Q2 2016$29,000
-3.3%
6,7560.0%0.00%
Q1 2016$30,000
-55.9%
6,7560.0%0.00%
Q4 2015$68,000
+33.3%
6,7560.0%0.00%
Q3 2015$51,000
-79.0%
6,756
+23.6%
0.00%
Q2 2015$243,000
+64.2%
5,467
+37.0%
0.00%
Q1 2015$148,000
-9.2%
3,9910.0%0.00%
Q4 2014$163,000
+87.4%
3,991
-7.8%
0.00%
Q3 2014$87,0004,3280.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2017
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 317,900$11,647,0004.28%
Opaleye Management Inc. 175,000$6,412,0002.98%
Graticule Asia Macro Advisors LLC 413,200$15,139,0002.02%
BB BIOTECH AG 1,477,114$54,121,0001.61%
Iguana Healthcare Management, LLC 75,000$2,748,0001.16%
Granite Point Capital Management, L.P. 79,250$2,904,0001.06%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 458,202$16,788,0000.89%
Ghost Tree Capital, LLC 130,000$4,764,0000.86%
SECTORAL ASSET MANAGEMENT INC 605,393$22,182,0000.84%
HealthCor Management, L.P. 467,200$17,118,0000.82%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders